Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.66 USD | +0.55% | +1.67% | +115.29% |
06-12 | Connect Biopharma Names New Chief Executive, Chair | MT |
05-29 | Heron Therapeutics Submits Prior Approval Supplement to the FDA for Zynrelef Vial Access Needle | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+115.29% | 548M | |
+48.54% | 56.87B | |
+37.15% | 39.72B | |
-6.02% | 39.27B | |
-6.90% | 28.73B | |
+12.97% | 26.21B | |
-16.91% | 19.79B | |
+31.71% | 12.28B | |
+28.18% | 12.23B | |
+0.38% | 12.12B |
- Stock Market
- Equities
- HRTX Stock
- News Heron Therapeutics, Inc.
- Transcript : Heron Therapeutics, Inc. - Analyst/Investor Day